Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A very rare morphologic variant of glomus tumor with a size greater than 2 cm. The tumor arises in subfascial or visceral tissues. It is characterized by the presence of atypical mitotic figures, or marked nuclear atypia, or the combination of both. It has an aggressive clinical course.
Biomarker and diagnostic research for malignant glomus tumor has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy and procedural interventions. Pipeline includes 1 PHASE1. Research is primarily sponsored by academic and government institutions.
140 publications have been identified in PubMed for malignant glomus tumor. Research spans Case Report / Case Series (55%), Review / Meta-Analysis (24%), and Clinical Trial Publication (6%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 77 |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 1:08 PM UTC
Research summaries | 34 | 24% |
Clinical study results | 9 | 6% |
Testing and diagnosis research | 6 | 4% |
Disease patterns and progression | 5 | 4% |
Laboratory research | 4 | 3% |
Other research | 3 | 2% |
New treatment approaches | 2 | 1% |
Su T (2026). [PMID: 41498833](https://pubmed.ncbi.nlm.nih.gov/41498833/). *Neuroradiology*. [Diagnostic / Biomarker]
Aggarwal G (2026). [PMID: 41870314](https://pubmed.ncbi.nlm.nih.gov/41870314/). *Int J Surg Pathol*. [Review / Meta-Analysis]
Luo S (2026). [PMID: 41866662](https://pubmed.ncbi.nlm.nih.gov/41866662/). *Clin Respir J*. [Review / Meta-Analysis]
Yu X (2026). [PMID: 41834553](https://pubmed.ncbi.nlm.nih.gov/41834553/). *Ann Ital Chir*. [Review / Meta-Analysis]
Marcoval J (2026). [PMID: 41217221](https://pubmed.ncbi.nlm.nih.gov/41217221/). *Int J Dermatol*. [Case Report / Case Series]
Satturwar S (2026). [PMID: 41651612](https://pubmed.ncbi.nlm.nih.gov/41651612/). *Surg Pathol Clin*. [Review / Meta-Analysis]
Mahtab P (2026). [PMID: 41914105](https://pubmed.ncbi.nlm.nih.gov/41914105/). *Mymensingh Med J*. [Epidemiology / Natural History]
Arshad H (2026). [PMID: 41801372](https://pubmed.ncbi.nlm.nih.gov/41801372/). *Abdom Radiol (NY)*. [Review / Meta-Analysis]
Alaseem A (2026). [PMID: 42137463](https://pubmed.ncbi.nlm.nih.gov/42137463/). *Oncol Lett*. [Case Report / Case Series]
Nassar A (2026). [PMID: 40371847](https://pubmed.ncbi.nlm.nih.gov/40371847/). *Dermatol Reports*. [Diagnostic / Biomarker]
AI-curated news mentioning malignant glomus tumor
Updated Apr 28, 2026
A case report details an unusual presentation of clear cell sarcoma in an adolescent, initially misdiagnosed as a glomus tumor. This highlights the need for careful differential diagnosis in rare tumors.